Nevertheless, the data imply that in pathological T1 lung adenocarcinoma, EGFR mutations are associated with preoperational serum carcinoembryonic levels ≥ 2.12 ng/mL. The gene discussed is EGFR; the disease is lung adenocarcinoma.